IOVANCE BIOTHERAPEUTICS, INC. (IOVA) › Total AssetsIOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $1.46M2011: $568.4K2012: $29.4K2013: $19.87M2014: $46.51M2015: $105.65M2016: $171.89M2017: $155.37M2018: $480.82M2019: $344.65M2020: $768.46M2021: $777.33M2022: $663.98M2023: $780.35M2024: $910.43M2025: $913.17M$913.17M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$913.17M+0.3%2024$910.43M+16.7%2023$780.35M+17.5%2022$663.98M-14.6%2021$777.33M+1.2%2020$768.46M+123.0%2019$344.65M-28.3%2018$480.82M+209.5%2017$155.37M-9.6%2016$171.89M+62.7%2015$105.65M+127.2%2014$46.51M+134.0%2013$19.87M+67467.6%2012$29.4K-94.8%2011$568.4K-61.1%2010$1.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share